drugset / Trial / NCT03919890

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

NCT03919890 ↗

Phase 1 Completed 72 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedSequentialDouble-blindTreatment

Summary

This is a first in human study to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of ONO-7684 in healthy adult volunteers. This study will be conducted in 2 parts: Part A is a single-ascending dose and Part B is a multiple-ascending dose.

Timeline

Start
2019-01-17
Primary completion
2019-08-23
Completion
2019-08-23

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-7684 Small molecule — Oral